| Evening Primrose References |
|
1. Mills S and Bone K. Principles and Practice of Phytotherapy. Churchill Livingstone, Edinburgh, UK 2000:363-373.
2. Botanical Medicine Class Notes. Bastyr University, Kenmore, WA. 2002.
3. Murray M and Pizzorno J. Encyclopedia of Natural Medicine, 2nd Ed. Prima Publishing, Rocklin, CA 1998:49-51.
4. Therapeutic Goods Administration. Approved Terminology for Drugs. Australian Government Publishing Service, Canberra, 1995.
5. Tyler et al. Pharmacognosy, 9th Ed. Lea and Febiger, Philadelphia, PA 1998:471.
6. Redden PR et al. Chem Phys Lipids 1996;79(1):9-19.
7. Yoon S, Lee J, Lee S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol Appl Skin Physiol 2002;15(1):20-25.
8. Biagi PL et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994;20(2):77-84.
9. Scotia Pharmaceuticals Ltd. Pioneering research in diabetic neuropathy. The EF4 project: the role of gamma-linolenic acid. Scotia Phramaceuticals Ltd, England 1991:11-16.
10. Jamal GA and Carmichael H. Diabet Med 1990;7(4):319-323.
11. Julu PO. J Diabetic Complicat 1988;2(4):185-188.
12. Tomlinson DR et al. Diabetologia 1989;32(9):655-659.
13. Puolakka J et al. J Reprod Med 1985;30(3):149-153.
14. Gateley CA et al. J Roy Soc Med 1992;85(1):12-15.
15. Haslett C, Douglas JG, Chalmers SR, et al. A double-blind evaluation of evening primrose oil as an antiobesity agent. Int J Obes 1983;7:549–553.
16. Belch JJ, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double-blind study. Thromb Haemost 1985;54:490–494.
17. Vaddadi KS et al. Psychiatry Res 1989;27(3):313-323.
18. Boyens J et al. S Afr J sci 1984;80:144.
19. D'Almeida A et al. Women's Health 1992;19(2-3):117-131.
20. Greenfield SM et al. Aliment Pharmacol Ther 1993;7(2):159-166.
21. Shuster J. Hosp Pharm 1996;31:1552-1554.
22. Lin Wan Po A. Pharmaceut J 1991;676-678.
23. Brinker F. Herb Contraindications and Drug Interactions, 3rd ed. Eclectic Medical Publications, Sandy, OR 2001:92.
24. Joe LA and Hart LL. Ann Pharmacother 1993;27(12):1475-1477.
|